Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status Tara SwartMichael J. Hurley Leading Article 08 November 2016 Pages: 1127 - 1135
B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence Silke KinzelMartin S. Weber Review Article 14 November 2016 Pages: 1137 - 1148
Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications Melinda LiuYuan Yu M. HuangJoseph S. Kass Review Article 10 November 2016 Pages: 1149 - 1168
Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies Tristram A. LettHenrik WalterEva J. Brandl Review Article 17 October 2016 Pages: 1169 - 1189
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review Rainer FreynhagenMiroslav BackonjaRegina Behar Review Article Open access 16 November 2016 Pages: 1191 - 1200
Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China Yingying SuGang LiuWeibi Chen Original Research Article 23 November 2016 Pages: 1201 - 1207
The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years Mark ZimmermanCarolina Guzman HolstDouglas Gazarian Original Research Article 19 August 2016 Pages: 1209 - 1218